Elevated CXCR4 expression on platelets in patients with CAD may, therefore, influence platelet CXCL14 binding, which is also more likely to be altered by epidemiologic and risk factors than circulating CXCL14. The gene discussed is CXCR4; the disease is coronary artery disorder.